Evidence map›Paper›PMID 40692842›Full record

ArticleERJ open research2025

Supporting clinical trial recruitment in COPD by leveraging lung cancer screening: an observational study.

Tanya Patrick, Sindhu Bhaarrati Naidu, Amyn Bhamani, Arafa Aboelhassan, Silvia Caño, Maria G Belvisi, Sarah R Doffman, Sam M Janes, John R Hurst

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in ERJ open research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Tanya PatrickUCL Respiratory, University College London, London, UK.
Sindhu Bhaarrati NaiduUCL Respiratory, University College London, London, UK.ORCID https://orcid.org/0000-0002-1106-6545
Amyn BhamaniUCL Respiratory, University College London, London, UK.
Arafa AboelhassanRoyal Free London NHS Foundation Trust, London, UK.ORCID https://orcid.org/0000-0001-8701-2693
Silvia CañoClinical Development, Early Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Barcelona, Spain.
Maria G BelvisiResearch and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.ORCID https://orcid.org/0000-0003-1652-4370
Sarah R DoffmanClinical Development, Early Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
Sam M JanesLungs for Living Research Centre, UCL Respiratory, University College London, London, UK.ORCID https://orcid.org/0000-0002-6634-5939
John R HurstUCL Respiratory, University College London, London, UK.ORCID https://orcid.org/0000-0002-7246-6040

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40692842
PMCPMC12278301

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.